Could we use clinical benefit to evaluate the effects of chinese medicine on the treatment of cancer?
Li
Ping-ping
PP
Peking University School of Oncology, Beijing Cancer Hospital, Beijing 100142, China. lppma123@yahoo.com.cn
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D006801:Humans; D008516:Medicine, Chinese Traditional / Q000379:methods*; D009369:Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000534:rehabilitation / Q000628:therapy*; D010166:Palliative Care / Q000379:methods; D011379:Prognosis; D011788:Quality of Life; D011878:Radiotherapy / Q000009:adverse effects; D018570:Risk Assessment; D016896:Treatment Outcome